Biomerica (NASDAQ:BMRA) Stock Price Crosses Below Two Hundred Day Moving Average – Here’s What Happened

Biomerica, Inc. (NASDAQ:BMRAGet Free Report) passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.36 and traded as low as $0.27. Biomerica shares last traded at $0.33, with a volume of 377,159 shares changing hands.

Biomerica Stock Down 3.0 %

The company has a market cap of $5.31 million, a price-to-earnings ratio of -0.85 and a beta of -1.10. The stock’s 50-day simple moving average is $0.33 and its 200 day simple moving average is $0.36.

Biomerica (NASDAQ:BMRAGet Free Report) last posted its quarterly earnings data on Tuesday, October 15th. The company reported ($0.08) earnings per share for the quarter. Biomerica had a negative return on equity of 84.62% and a negative net margin of 111.89%. The company had revenue of $1.81 million for the quarter.

Hedge Funds Weigh In On Biomerica

An institutional investor recently bought a new position in Biomerica stock. Perritt Capital Management Inc purchased a new position in shares of Biomerica, Inc. (NASDAQ:BMRAFree Report) during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 70,000 shares of the company’s stock, valued at approximately $31,000. Perritt Capital Management Inc owned 0.42% of Biomerica at the end of the most recent reporting period. Institutional investors own 22.28% of the company’s stock.

About Biomerica

(Get Free Report)

Biomerica, Inc, a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.

Read More

Receive News & Ratings for Biomerica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biomerica and related companies with MarketBeat.com's FREE daily email newsletter.